These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32436947)
21. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]
22. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801 [TBL] [Abstract][Full Text] [Related]
23. Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease. Franciosi S; Ryu JK; Shim Y; Hill A; Connolly C; Hayden MR; McLarnon JG; Leavitt BR Neurobiol Dis; 2012 Jan; 45(1):438-49. PubMed ID: 21946335 [TBL] [Abstract][Full Text] [Related]
24. Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome. Bianchi P; Bettini S; Guidi S; Ciani E; Trazzi S; Stagni F; Ragazzi E; Franceschini V; Bartesaghi R Exp Neurol; 2014 Jan; 251():1-11. PubMed ID: 24192151 [TBL] [Abstract][Full Text] [Related]
25. Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease. Carroll JB; Lerch JP; Franciosi S; Spreeuw A; Bissada N; Henkelman RM; Hayden MR Neurobiol Dis; 2011 Jul; 43(1):257-65. PubMed ID: 21458571 [TBL] [Abstract][Full Text] [Related]
26. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Southwell AL; Franciosi S; Villanueva EB; Xie Y; Winter LA; Veeraraghavan J; Jonason A; Felczak B; Zhang W; Kovalik V; Waltl S; Hall G; Pouladi MA; Smith ES; Bowers WJ; Zauderer M; Hayden MR Neurobiol Dis; 2015 Apr; 76():46-56. PubMed ID: 25662335 [TBL] [Abstract][Full Text] [Related]
27. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236 [TBL] [Abstract][Full Text] [Related]
28. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620 [TBL] [Abstract][Full Text] [Related]
29. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753 [TBL] [Abstract][Full Text] [Related]
30. Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein. Zhang S; Xiao Q; Le W PLoS One; 2015; 10(3):e0119928. PubMed ID: 25799501 [TBL] [Abstract][Full Text] [Related]
32. Olfactory deficit is associated with mitral cell dysfunction in the olfactory bulb of P301S tau transgenic mice. Li S; Li W; Wu X; Li J; Yang J; Tu C; Ye X; Ling S Brain Res Bull; 2019 May; 148():34-45. PubMed ID: 30902575 [TBL] [Abstract][Full Text] [Related]
33. Cell-Type-Specific Modulation of Sensory Responses in Olfactory Bulb Circuits by Serotonergic Projections from the Raphe Nuclei. Brunert D; Tsuno Y; Rothermel M; Shipley MT; Wachowiak M J Neurosci; 2016 Jun; 36(25):6820-35. PubMed ID: 27335411 [TBL] [Abstract][Full Text] [Related]
34. A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes. Petrella LI; Castelhano JM; Ribeiro M; Sereno JV; Gonçalves SI; Laço MN; Hayden MR; Rego AC; Castelo-Branco M Hum Mol Genet; 2018 Jun; 27(12):2125-2137. PubMed ID: 29668904 [TBL] [Abstract][Full Text] [Related]
35. Expression of the NMDA receptor subunit GluN3A (NR3A) in the olfactory system and its regulatory role on olfaction in the adult mouse. Lee JH; Wei L; Deveau TC; Gu X; Yu SP Brain Struct Funct; 2016 Jul; 221(6):3259-73. PubMed ID: 26334321 [TBL] [Abstract][Full Text] [Related]
36. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219 [TBL] [Abstract][Full Text] [Related]
37. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Rey NL; Wesson DW; Brundin P Neurobiol Dis; 2018 Jan; 109(Pt B):226-248. PubMed ID: 28011307 [TBL] [Abstract][Full Text] [Related]
38. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease. Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392 [TBL] [Abstract][Full Text] [Related]
39. Retinoic acid receptor-dependent survival of olfactory sensory neurons in postnatal and adult mice. Hägglund M; Berghard A; Strotmann J; Bohm S J Neurosci; 2006 Mar; 26(12):3281-91. PubMed ID: 16554478 [TBL] [Abstract][Full Text] [Related]
40. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]